Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description At NIQ, we are committed to helping clients grow by delivering a deep understanding of consumer behavior through advanced data, analytics, and technology. Our Strategic Analytics & Insights (SA&I) team plays a critical role
Work Schedule Environmental Conditions Job Description As part of the Thermo Fisher Scientific team, you’ll discover meaningful work that makes a positive impact on a global scale. Join our colleagues in bringing our Mission to life